CSX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
CSX Corp is not a strong buy for a beginner, long-term investor at this moment. While the stock has shown some positive indicators, such as a dividend increase and stable cash flow, the lack of strong growth in financial performance, hedge fund selling, and mixed analyst ratings suggest a cautious approach. The current price does not present a compelling entry point for long-term gains.
The technical indicators show a mixed picture. The MACD is positive but contracting, RSI is neutral at 75.866, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 42.588), indicating limited immediate upside. The pre-market and post-market price changes are slightly negative, suggesting weak momentum.
Dividend increase of 8% to $0.14 per share, reflecting stable cash flow and boosting investor confidence.
Infosys data modernization program for CSX, enhancing decision-making efficiency.
Hedge funds are aggressively selling, with a 6358.05% increase in selling activity over the last quarter.
Q4 financials showed a decline in revenue (-0.88% YoY) and net income (-1.77% YoY), with only a modest EPS growth of 2.63%.
Mixed analyst ratings and reduced price targets from several firms.
In Q4 2025, CSX reported a revenue decline of 0.88% YoY to $3.51 billion and a net income drop of 1.77% YoY to $720 million. EPS increased by 2.63% YoY to $0.39, but gross margin fell by 1.96% YoY to 58.01%. The financial performance reflects weak growth trends.
Analyst ratings are mixed. While some firms like Citi and RBC Capital maintain a positive outlook with price targets around $40-$41, others like Bernstein and Evercore highlight cautious macroeconomic conditions, weak Q4 results, and limited upside. The average price target aligns closely with the current stock price, suggesting limited growth potential in the near term.
